Clinical Trial Update: FUSCC Refractory TNBC Umbrella (FUTURE) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for the FUTURE umbrella study in refractory triple-negative breast cancer spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Triple-negative Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN